DaVita
DVA
#1760
Rank
C$16.48 B
Marketcap
C$262.13
Share price
-3.01%
Change (1 day)
57.13%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): C$17.41

According to DaVita's latest financial reports the company's current EPS (TTM) is C$17.45. In 2025 the company made an earnings per share (EPS) of C$14.15 a decrease over its 2024 EPS that were of C$15.42.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$17.4123.05%
2025C$14.15-8.25%
2024C$15.4244.94%
2023C$10.6427.26%
2022C$8.36-35.56%
2021C$12.9744.1%
2020C$9.0019.7%
2019C$7.52540.48%
2018C$1.17-76.07%
2017C$4.91-19.31%
2016C$6.08242.52%
2015C$1.78-62.87%
2014C$4.7813.43%
2013C$4.218.45%
2012C$3.89

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
C$34.71 98.96%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
C$17.01-2.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
C$36.52 109.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
C$2.96-83.04%๐Ÿ‡บ๐Ÿ‡ธ USA